Search results
Author(s):
Nehal Dhaduk
,
Adib Chaus
,
David Williams
,
et al
Added:
1 month ago
Author(s):
Kelly H Schlendorf
,
Jared O’Leary
,
JoAnn Lindenfeld
Added:
3 years ago
Mitral regurgitation (MR) is common in industrialized countries, with a prevalence of about 2% in the general population and about 9% in people over 75 years old.1,2 MR is classified as primary/degenerative when it results from a structural abnormality of the valve apparatus, or secondary/functional when it results from a disturbance of ventricular or annular geometry and/or function that impairs…
View more
Author(s):
Suzanne J Baron
Added:
3 years ago
In the wake of transcatheter aortic valve replacement revolutionizing the treatment of aortic stenosis, sizeable interest has arisen in the development of percutaneous technologies to treat patients with mitral valve disease. Thus, when a percutaneous method of edge-to-edge mitral valve repair (TMVr) using the MitraClip device (Abbott Vascular) was introduced, this device was met with…
View more
Author(s):
Mehmet Ali Elbey
,
Luis Augusto Palma Dallan
,
Guilherme Ferragut Attizzani
Added:
3 years ago
The field of mitral valve disease diagnosis and management is in constant change. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities have led to more complex treatments. Transcatheter mitral valve repair with a MitraClip device is resulting in good outcomes in patients with primary mitral regurgitation who are at high…
View more
TCT 2018: REDUCE-FMR
Author(s):
Horst Sievert
Added:
5 years ago
Video
TCT 2018: COAPT
Author(s):
Sameer Gafoor
Added:
5 years ago
Video
Author(s):
Federico M Asch
Added:
5 years ago
Dr Federico M Asch (Washington Hospital Center, Washington DC, US) discusses echocardiographic outcomes from the COAPT trial - mitral regurgitation after MitraClip implantation in patients with HF and secondary mitral regurgitation.Filmed on-site at ACC 2019 by Radcliffe Cardiology.
Videographer: Josh Birch
Educational Lead: Liam O'Neill, Chief Operating Officer
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science.
Studies include:…
View more
Foreword
Author(s):
Ankur Kalra
Added:
3 years ago
Article
Author(s):
Vikram Sharma
,
Arpit Sothwal
,
Jai Parekh
,
et al
Added:
1 year ago